Literature DB >> 17613419

At last--progress in the assessment of the adverse effects of cancer treatments.

Jean-Claude Horiot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17613419     DOI： 10.1016/S1470-2045(07)70183-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  Quantitative tool to evaluate the somatic burden due to chemotherapy-induced adverse events: the somatic burden score.

Authors:  Michael Koehler; Thomas Fischer; Siegfried Kropf; Joerg Frommer
Journal:  Support Care Cancer       Date:  2014-07-05       Impact factor: 3.603

2.  Small interfering RNA targeting of the survivin gene inhibits human tumor cell growth in vitro.

Authors:  Zhaoxia Zhang; Tianyou Wang; Ziqin Liu; Suoqin Tang; Mei Yue; Shunqiao Feng; Mengze Hu; Litian Xuan; Yanfei Chen
Journal:  Exp Ther Med       Date:  2017-05-23       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.